Leveraging Landmark Analysis for Tailored Surveillance in Stage I Non-Small-Cell Lung Cancer. [PDF]
Leuzzi G +12 more
europepmc +1 more source
Understanding Non-Small-Cell Lung Cancer: Biology, Therapeutics and Drug Resistance. [PDF]
Ahluwalia P, Kolhe R, Rojiani M.
europepmc +1 more source
Lactotransferrin upregulation affects the pathological changes of non-small cell lung cancer by regulating ferroptosis. [PDF]
Wang Y, Xu W, Ren K, Min L.
europepmc +1 more source
Current advances in mediastinal staging for non-small cell lung cancer: a narrative review. [PDF]
Minervini F +4 more
europepmc +1 more source
[Retracted] MicroRNA‑4500 suppresses tumor progression in non‑small cell lung cancer by regulating STAT3. [PDF]
Li ZY +7 more
europepmc +1 more source
Maximum standardized uptake value significance in clinical stage IB-IIIB non-small cell lung cancer. [PDF]
Shigefuku S +8 more
europepmc +1 more source
Immunotherapy in EGFR-mutant non-small cell lung cancer. [PDF]
Wang L, Xian X, Ke H, Wang K.
europepmc +1 more source
Erratum: Endoplasmic reticulum stress in non-small cell lung cancer. [PDF]
Li X +6 more
europepmc +1 more source

